Inspec

Inspec EBIT per Share

The EBIT per Share of Inspec (6656.T) as of Oct 21, 2026 is 39.52 JPY. In the previous year, EBIT per Share was 27.09 JPY — a change of 45.86% (higher).

EBIT per Share

39.52JPY

YoY

45.86%

Last updated:

EBIT per Share of Inspec is 2026 39.52 JPY. EBIT per Share of Inspec was 2025 27.09 JPY. It decreases by 45.86% higher compared to the previous year.

The Inspec EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
43.47 JPY
Jan 1, 2021
-70.47 JPY
Jan 1, 2022
4.76 JPY
Jan 1, 2023
34.05 JPY
Jan 1, 2024
-58.21 JPY
Jan 1, 2025
27.09 JPY
Jan 1, 2026
39.52 JPY
Jan 1, 2027 (e)
0.00 JPY
The Inspec EBIT per Share history
YEAREBIT per ShareYoY
est0.00JPY-100.00%
39.52JPY+45.86%
27.09JPY-146.55%
-58.21JPY-270.93%
34.05JPY+615.66%
4.76JPY-106.75%
-70.47JPY-262.10%
43.47JPY-54.61%
95.77JPY-225.60%
-76.25JPY-252.14%
50.12JPY-765.41%
-7.53JPY-118.32%
41.10JPY+97.25%
20.84JPY-109.05%
-230.29JPY+48.07%
-155.53JPY-1,641.25%
10.09JPY-104.79%
-210.46JPY-72.60%
-768.08JPY+3,460.87%
-21.57JPY-233.16%
16.20JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

EBIT per Share of Inspec is 39.52 JPY in 2026.

EBIT per Share of Inspec changed from 27.09 JPY to 39.52 JPY, representing a 45.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Inspec since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Inspec

All Key Metrics — Inspec